956.7K XNAS Volume
XNAS 18 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 2,344 | 9,375 | - | - | Restricted Stock Unit | |
| Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 2,344 | 405,472 (1%) | 0% | - | Common Stock | |
| Michael Kaseta | CFO and COO | Sale of securities on an exchange or to another person at price $ 15.45 per share. | 28 Feb 2025 | 874 | 404,598 (1%) | 0% | 15.4 | 13,503 | Common Stock |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 1,562 | 6,250 | - | - | Restricted Stock Unit | |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 15.45 per share. | 28 Feb 2025 | 451 | 182,254 (0%) | 0% | 15.5 | 6,968 | Common Stock |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 1,562 | 182,705 (0%) | 0% | - | Common Stock | |
| Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 2,344 | 577,195 (2%) | 0% | - | Common Stock | |
| Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 2,343 | 9,375 | - | - | Restricted Stock Unit | |
| Russell Schundler | General Counsel | Sale of securities on an exchange or to another person at price $ 15.45 per share. | 28 Feb 2025 | 930 | 576,265 (2%) | 0% | 15.5 | 14,369 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 1,875 | 7,500 | - | - | Restricted Stock Unit | |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 1,875 | 218,742 (0%) | 0% | - | Common Stock | |
| Scott Moomaw | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 15.45 per share. | 28 Feb 2025 | 592 | 218,150 (0%) | 0% | 15.4 | 9,146 | Common Stock |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 14.20 per share. | 27 Jan 2025 | 445 | 179,770 (0%) | 0% | 14.2 | 6,319 | Common Stock |
| Rajeev Saggar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 21 Jan 2025 | 2,445 | 267,943 (0%) | 0% | 13 | 31,785 | Common Stock |
| Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 229,327 | 229,327 | - | - | Performance Stock Units | |
| Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 229,327 | 1,041,520 (3%) | 0% | 0 | Common Stock | |
| Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.78 per share. | 11 Jan 2025 | 22,343 | 1,019,177 (3%) | 0% | 11.8 | 263,201 | Common Stock |
| Michael Kaseta | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 112,797 | 112,797 | - | - | Performance Stock Units | |
| Michael Kaseta | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 112,797 | 425,125 (1%) | 0% | 0 | Common Stock | |
| Michael Kaseta | CFO and COO | Sale of securities on an exchange or to another person at price $ 11.78 per share. | 11 Jan 2025 | 23,370 | 401,755 (1%) | 0% | 11.8 | 275,299 | Common Stock |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2025 | 3,906 | 185,024 (0%) | 0% | - | Common Stock | |
| Jason Adair | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 61,895 | 181,118 (0%) | 0% | 0 | Common Stock | |
| Jason Adair | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 61,895 | 61,895 | - | - | Performance Stock Units | |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.78 per share. | 11 Jan 2025 | 4,809 | 180,215 (0%) | 0% | 11.8 | 56,650 | Common Stock |
| Russell Schundler | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 102,543 | 102,543 | - | - | Performance Stock Units | |
| Russell Schundler | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 102,543 | 589,871 (2%) | 0% | 0 | Common Stock | |
| Russell Schundler | General Counsel | Sale of securities on an exchange or to another person at price $ 11.78 per share. | 11 Jan 2025 | 16,393 | 573,478 (2%) | 0% | 11.8 | 193,110 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 69,729 | 69,729 | - | - | Performance Stock Units | |
| Scott Moomaw | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 11.78 per share. | 11 Jan 2025 | 8,362 | 215,494 (0%) | 0% | 11.8 | 98,504 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 69,729 | 223,856 (0%) | 0% | 0 | Common Stock | |
| Rajeev Saggar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 71,780 | 71,780 | - | - | Performance Stock Units | |
| Rajeev Saggar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.78 per share. | 11 Jan 2025 | 6,249 | 270,388 (0%) | 0% | 11.8 | 73,613 | Common Stock |
| Rajeev Saggar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 71,780 | 276,637 (0%) | 0% | 0 | Common Stock | |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2024 | 1,875 | 154,673 (0%) | 0% | - | Common Stock | |
| Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2024 | 2,343 | 11,719 | - | - | Restricted Stock Unit | |
| Schundler Russell | General Counsel | Sale of securities on an exchange or to another person at price $ 11.51 per share. | 30 Nov 2024 | 1,063 | 487,328 (1%) | 0% | 11.5 | 12,235 | Common Stock |
| Michael Kaseta | CFO and COO | Sale of securities on an exchange or to another person at price $ 11.51 per share. | 30 Nov 2024 | 1,091 | 312,328 (1%) | 0% | 11.5 | 12,557 | Common Stock |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2024 | 1,563 | 119,678 (0%) | 0% | - | Common Stock | |
| Moomaw Scott | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2024 | 1,875 | 9,375 | - | - | Restricted Stock Unit | |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.51 per share. | 30 Nov 2024 | 455 | 119,223 (0%) | 0% | 11.5 | 5,237 | Common Stock |
| Kaseta Michael | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2024 | 2,343 | 11,719 | - | - | Restricted Stock Unit | |
| Adair Jason | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2024 | 1,563 | 7,812 | - | - | Restricted Stock Unit | |
| Moomaw Scott | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 11.51 per share. | 30 Nov 2024 | 546 | 154,127 (0%) | 0% | 11.5 | 6,284 | Common Stock |
| Schundler Russell | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2024 | 2,343 | 488,391 (1%) | 0% | - | Common Stock | |
| Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2024 | 2,343 | 313,419 (1%) | 0% | - | Common Stock | |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.31 per share. | 28 Oct 2024 | 459 | 118,115 (0%) | 0% | 11.3 | 5,190 | Common Stock |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.31 per share. | 28 Oct 2024 | 459 | 118,115 (0%) | 0% | 11.3 | 5,190 | Common Stock |
| Rajeev Saggar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.19 per share. | 18 Oct 2024 | 2,526 | 204,857 (0%) | 0% | 11.2 | 28,266 | Common Stock |
| Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.11 per share. | 14 Oct 2024 | 8,053 | 812,193 (2%) | 0% | 11.1 | 89,450 | Common Stock |
| Michael Kaseta | CFO and COO | Sale of securities on an exchange or to another person at price $ 11.11 per share. | 14 Oct 2024 | 3,892 | 311,076 (1%) | 0% | 11.1 | 43,231 | Common Stock |
| Russell Schundler | General Counsel | Sale of securities on an exchange or to another person at price $ 11.11 per share. | 14 Oct 2024 | 2,576 | 486,048 (1%) | 0% | 11.1 | 28,613 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 11.11 per share. | 14 Oct 2024 | 1,527 | 152,798 (0%) | 0% | 11.1 | 16,961 | Common Stock |
| Rajeev Saggar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.11 per share. | 14 Oct 2024 | 2,260 | 207,383 (0%) | 0% | 11.1 | 25,103 | Common Stock |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2024 | 3,906 | 119,720 (0%) | 0% | - | Common Stock | |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2024 | 3,906 | 35,156 | - | - | Restricted Stock Unit | |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.11 per share. | 11 Oct 2024 | 1,146 | 118,574 (0%) | 0% | 11.1 | 12,729 | Common Stock |
| Paul B. Manning | Director | Purchase of securities on an exchange or from another person at price $ 8.90 per share. | 12 Sep 2024 | 337,078 | 816,311 (2%) | 1% | 8.9 | 2,999,994 | Common Stock |
| Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 2,344 | 316,047 (1%) | 0% | - | Common Stock | |
| Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 2,344 | 14,062 | - | - | Restricted Stock Unit | |
| Michael Kaseta | CFO and COO | Sale of securities on an exchange or to another person at price $ 9.50 per share. | 30 Aug 2024 | 1,079 | 314,968 (1%) | 0% | 9.5 | 10,250 | Common Stock |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 9.50 per share. | 30 Aug 2024 | 455 | 115,814 (0%) | 0% | 9.5 | 4,322 | Common Stock |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 1,562 | 9,375 | - | - | Restricted Stock Unit | |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 1,562 | 116,269 (0%) | 0% | - | Common Stock | |
| Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 2,344 | 14,062 | - | - | Restricted Stock Unit | |
| Russell Schundler | General Counsel | Sale of securities on an exchange or to another person at price $ 9.50 per share. | 30 Aug 2024 | 710 | 488,624 (1%) | 0% | 9.5 | 6,745 | Common Stock |
| Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 2,344 | 489,334 (1%) | 0% | - | Common Stock | |
| Scott Moomaw | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 9.50 per share. | 30 Aug 2024 | 546 | 154,325 (0%) | 0% | 9.5 | 5,187 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 1,875 | 11,250 | - | - | Restricted Stock Unit | |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2024 | 1,875 | 154,871 (0%) | 0% | - | Common Stock | |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.44 per share. | 26 Jul 2024 | 1,833 | 113,393 (0%) | 0% | 11.4 | 20,970 | Common Stock |
| Rajeev Saggar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.13 per share. | 19 Jul 2024 | 1,873 | 208,329 (0%) | 0% | 11.1 | 20,846 | Common Stock |
| Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 12 Jul 2024 | 8,053 | 818,932 (2%) | 0% | 12.5 | 100,904 | Common Stock |
| Michael Kaseta | CFO and COO | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 12 Jul 2024 | 3,906 | 312,389 (1%) | 0% | 12.5 | 48,942 | Common Stock |
| Russell Schundler | General Counsel | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 12 Jul 2024 | 1,985 | 485,676 (1%) | 0% | 12.5 | 24,872 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 12 Jul 2024 | 1,528 | 151,682 (0%) | 0% | 12.5 | 19,146 | Common Stock |
| Rajeev Saggar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 12 Jul 2024 | 1,470 | 210,202 (0%) | 0% | 12.5 | 18,419 | Common Stock |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2024 | 3,907 | 116,372 (0%) | 0% | - | Common Stock | |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2024 | 3,907 | 39,062 | - | - | Restricted Stock Unit | |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 11 Jul 2024 | 1,146 | 115,226 (0%) | 0% | 12.5 | 14,359 | Common Stock |
| Arthur S. Kirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,359 | 22,359 (0%) | 0% | 0 | Common Stock | |
| Stephen Bloch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,359 | 20,359 (0%) | 0% | 0 | Common Stock | |
| Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,359 | 299,689 (1%) | 0% | 0 | Common Stock | |
| Joanna Horobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,359 | 20,359 (0%) | 0% | 0 | Common Stock | |
| Ramandeep Singh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,359 | 20,359 (0%) | 0% | 0 | Common Stock | |
| Katherine Rielly-Gauvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,359 | 20,359 (0%) | 0% | 0 | Common Stock | |
| Damian deGoa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,359 | 68,075 (0%) | 0% | 0 | Common Stock | |
| Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 2,344 | 317,389 (1%) | 0% | - | Common Stock | |
| Michael Kaseta | CFO and COO | Sale of securities on an exchange or to another person at price $ 14.55 per share. | 31 May 2024 | 1,094 | 316,295 (1%) | 0% | 14.6 | 15,918 | Common Stock |
| Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 2,344 | 16,406 | - | - | Restricted Stock Unit | |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 1,563 | 112,920 (0%) | 0% | - | Common Stock | |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 1,563 | 10,937 | - | - | Restricted Stock Unit | |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 14.55 per share. | 31 May 2024 | 455 | 112,465 (0%) | 0% | 14.5 | 6,620 | Common Stock |
| Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 2,344 | 488,371 (1%) | 0% | - | Common Stock | |
| Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 2,344 | 16,406 | - | - | Restricted Stock Unit | |
| Russell Schundler | General Counsel | Sale of securities on an exchange or to another person at price $ 14.55 per share. | 31 May 2024 | 710 | 487,661 (1%) | 0% | 14.6 | 10,331 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 1,875 | 153,756 (0%) | 0% | - | Common Stock | |
| Scott Moomaw | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 14.55 per share. | 31 May 2024 | 546 | 153,210 (0%) | 0% | 14.5 | 7,944 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 1,875 | 13,125 | - | - | Restricted Stock Unit | |
| Rajeev Saggar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.68 per share. | 19 Apr 2024 | 1,649 | 211,672 (0%) | 0% | 13.7 | 22,558 | Common Stock |
| Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 12 Apr 2024 | 8,360 | 826,985 (2%) | 0% | 14.6 | 121,889 | Common Stock |
| Michael Kaseta | CFO and COO | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 12 Apr 2024 | 3,136 | 315,045 (1%) | 0% | 14.6 | 45,723 | Common Stock |
| Russell Schundler | General Counsel | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 12 Apr 2024 | 2,060 | 486,027 (1%) | 0% | 14.6 | 30,035 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 12 Apr 2024 | 1,585 | 151,881 (0%) | 0% | 14.6 | 23,109 | Common Stock |
| Rajeev Saggar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 12 Apr 2024 | 1,525 | 213,321 (0%) | 0% | 14.6 | 22,235 | Common Stock |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 3,906 | 112,546 (0%) | 0% | - | Common Stock | |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 3,906 | 42,969 | - | - | Restricted Stock Unit | |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 11 Apr 2024 | 1,189 | 111,537 (0%) | 0% | 14.6 | 17,336 | Common Stock |
| Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2024 | 2,344 | 330,347 (1%) | 0% | - | Common Stock | |
| Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2024 | 2,344 | 18,750 | - | - | Restricted Stock Unit | |
| Michael Kaseta | CFO and COO | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 19 Mar 2024 | 11,315 | 318,181 (1%) | 0% | 15.8 | 179,003 | Common Stock |
| Michael Kaseta | CFO and COO | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 19 Mar 2024 | 851 | 329,496 (1%) | 0% | 15.8 | 13,463 | Common Stock |
| Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 18 Mar 2024 | 28,583 | 835,345 (2%) | 0% | 15.8 | 452,183 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 18 Mar 2024 | 6,108 | 153,466 (0%) | 0% | 15.8 | 96,629 | Common Stock |
| Rajeev Saggar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 18 Mar 2024 | 5,876 | 214,846 (0%) | 0% | 15.8 | 92,958 | Common Stock |
| Rajeev Saggar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 18 Mar 2024 | 1,654 | 220,722 (0%) | 0% | 15.8 | 26,166 | Common Stock |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 15.50 per share. | 15 Mar 2024 | 76 | 108,640 (0%) | 0% | 15.5 | 1,178 | Common Stock |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 260 | 113,297 (0%) | 0% | - | Common Stock | |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 15,625 | 113,037 (0%) | 0% | - | Common Stock | |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 260 | 0 | - | - | Restricted Stock Unit | |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 15,625 | 46,875 | - | - | Restricted Stock Unit | |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 15 Mar 2024 | 4,581 | 108,716 (0%) | 0% | 15.8 | 72,471 | Common Stock |
| Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 2,344 | 496,740 (1%) | 0% | - | Common Stock | |
| Russell Schundler | General Counsel | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 15 Mar 2024 | 715 | 496,025 (1%) | 0% | 15.8 | 11,311 | Common Stock |
| Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 2,344 | 18,750 | - | - | Restricted Stock Unit | |
| Russell Schundler | General Counsel | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 15 Mar 2024 | 7,938 | 488,087 (1%) | 0% | 15.8 | 125,579 | Common Stock |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 1,562 | 97,867 (0%) | 0% | - | Common Stock | |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 1,562 | 12,500 | - | - | Restricted Stock Unit | |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 14.17 per share. | 29 Feb 2024 | 455 | 97,412 (0%) | 0% | 14.2 | 6,447 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 1,875 | 160,120 (0%) | 0% | - | Common Stock | |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 1,875 | 15,000 | - | - | Restricted Stock Unit | |
| Scott Moomaw | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 14.17 per share. | 29 Feb 2024 | 546 | 159,574 (0%) | 0% | 14.2 | 7,737 | Common Stock |
| Russell Schundler | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 60,135 | 60,135 | - | - | Performance Stock Units | |
| Adair Jason | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 39,588 | 94,520 (0%) | 0% | 0 | Common Stock | |
| Kaseta Michael | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 93,250 | 276,250 (0%) | 0% | 0 | Common Stock | |
| Moomaw Scott | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 49,723 | 49,723 | - | - | Performance Stock Units | |
| Russell Schundler | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 110,135 | 492,611 (1%) | 0% | 0 | Common Stock | |
| Rajeev Saggar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 56,492 | 220,591 (0%) | 0% | 0 | Common Stock | |
| Michael Kaseta | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 93,250 | 93,250 | - | - | Performance Stock Units | |
| Jason Adair | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 39,588 | 39,588 | - | - | Performance Stock Units | |
| A. Jeffs Roger | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 221,338 | 221,338 | - | - | Performance Stock Units | |
| Rajeev Saggar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 56,492 | 56,492 | - | - | Performance Stock Units | |
| Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 221,338 | 862,143 (3%) | 0% | 0 | Common Stock | |
| Moomaw Scott | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 49,723 | 156,460 (0%) | 0% | 0 | Common Stock | |
| Kaseta Michael | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 50,000 | 326,250 (1%) | 0% | 0 | Common Stock | |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2023 | 261 | 55,009 (0%) | 0% | - | Common Stock | |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2023 | 261 | 260 | - | - | Restricted Stock Unit | |
| Jason Adair | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 7.70 per share. | 18 Dec 2023 | 77 | 54,932 (0%) | 0% | 7.7 | 593 | Common Stock |
| Saggar Rajeev | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.42 per share. | 15 Dec 2023 | 14,887 | 164,099 (0%) | 0% | 7.4 | 110,462 | Common Stock |
| A. Roger Jeffs | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.16 per share. | 14 Dec 2023 | 139,665 | 640,805 (2%) | 0% | 7.2 | 1,000,001 | Common Stock |
| Manning Paul B. | Director | Purchase of securities on an exchange or from another person at price $ 7.16 per share. | 14 Dec 2023 | 279,330 | 279,330 (0%) | 0% | 7.2 | 2,000,003 | Common Stock |
| Moomaw Scott | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 7.28 per share. | 30 Nov 2023 | 542 | 106,737 (0%) | 0% | 7.3 | 3,946 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2023 | 1,875 | 107,279 (0%) | 0% | - | Common Stock | |
| Jason Adair | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2023 | 1,563 | 55,200 (0%) | 0% | - | Common Stock | |
| Adair Jason | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2023 | 1,563 | 14,062 | - | - | Restricted Stock Unit | |
| Kaseta Michael | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2023 | 2,343 | 21,094 | - | - | Restricted Stock Unit | |
| Adair Jason | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 7.28 per share. | 30 Nov 2023 | 452 | 54,478 (0%) | 0% | 7.3 | 3,291 | Common Stock |
| Kaseta Michael | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2023 | 2,343 | 183,000 (0%) | 0% | - | Common Stock | |
| A. Lippe Robert | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2023 | 1,718 | 15,469 | - | - | Restricted Stock Unit | |
| Schundler Russell | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2023 | 2,343 | 382,476 (1%) | 0% | - | Common Stock | |
| A. Robert Lippe | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 7.28 per share. | 30 Nov 2023 | 497 | 193,788 (0%) | 0% | 7.3 | 3,618 | Common Stock |
| Lippe A. Robert | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2023 | 1,718 | 194,285 (0%) | 0% | - | Common Stock | |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2023 | 1,875 | 16,875 | - | - | Restricted Stock Unit | |
| Schundler Russell | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2023 | 2,343 | 21,094 | - | - | Restricted Stock Unit | |
| Arthur S. Kirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2023 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Stephen Bloch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2023 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2023 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Joanna Horobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2023 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Raman Singh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2023 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Katherine Rielly-Gauvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2023 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Damian deGoa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Robert A. Lippe | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 1,719 | 18,906 | - | - | Restricted Stock Unit | |
| Robert A. Lippe | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 8.08 per share. | 31 May 2023 | 597 | 189,646 (0%) | 0% | 8.1 | 4,824 | Common Stock |
| Robert A. Lippe | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 1,719 | 190,243 (0%) | 0% | - | Common Stock | |
| Michael Kaseta | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 2,344 | 176,597 (0%) | 0% | - | Common Stock | |
| Michael Kaseta | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 2,344 | 25,781 | - | - | Restricted Stock Unit | |
| Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 2,344 | 375,970 (1%) | 0% | - | Common Stock | |
| Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 2,344 | 25,781 | - | - | Restricted Stock Unit | |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 1,875 | 102,919 (0%) | 0% | - | Common Stock | |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 1,875 | 20,625 | - | - | Restricted Stock Unit | |
| Scott Moomaw | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.08 per share. | 31 May 2023 | 651 | 102,268 (0%) | 0% | 8.1 | 5,260 | Common Stock |
| Robert A. Lippe | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 6,875 | 20,625 | - | - | Restricted Stock Unit | |
| Robert A. Lippe | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 6,875 | 190,557 (0%) | 0% | - | Common Stock | |
| Robert A. Lippe | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 7.56 per share. | 28 Feb 2023 | 2,033 | 188,524 (0%) | 0% | 7.6 | 15,362 | Common Stock |
| Michael Kaseta | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 9,375 | 28,125 | - | - | Restricted Stock Unit | |
| Michael Kaseta | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 9,375 | 174,253 (0%) | 0% | - | Common Stock | |
| Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 9,375 | 373,626 (1%) | 0% | - | Common Stock | |
| Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 9,375 | 28,125 | - | - | Restricted Stock Unit | |
| Scott Moomaw | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 7.56 per share. | 28 Feb 2023 | 2,171 | 101,044 (0%) | 0% | 7.6 | 16,405 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 7,500 | 22,500 | - | - | Restricted Stock Unit | |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 7,500 | 103,155 (0%) | 0% | - | Common Stock | |
| Scott Moomaw | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 7.56 per share. | 28 Feb 2023 | 2,171 | 100,984 (0%) | 0% | 7.6 | 16,405 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 7,500 | 22,500 | - | - | Restricted Stock Unit | |
| Scott Moomaw | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 7,500 | 103,215 (0%) | 0% | - | Common Stock | |
| Robert A. Lippe | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 106,838 | 106,838 | - | - | Stock Option (Right to Buy) | |
| Robert A. Lippe | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 83,333 | 181,359 (0%) | 0% | 0 | Common Stock | |
| Russell Schundler | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 104,167 | 361,679 (1%) | 0% | 0 | Common Stock | |
| Russell Schundler | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 133,547 | 133,547 | - | - | Stock Option (Right to Buy) | |
| Rajeev Saggar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 106,838 | 106,838 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Rajeev Saggar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 83,333 | 177,167 (0%) | 0% | 0 | Common Stock | |
| Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 15,807 | 207,249 (0%) | 0% | - | Common Stock | |
| Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 15,807 | 0 | - | - | Restricted Stock Unit | |
| Michael Kaseta | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 5.99 per share. | 13 Sep 2022 | 8,000 | 37,877 (0%) | 0% | 6.0 | 47,920 | Common Stock |
| Roger A. Jeffs | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.57 per share. | 06 Sep 2022 | 43,820 | 159,827 (0%) | 0% | 5.6 | 243,990 | Common Stock |
| Russell Schundler | General Counsel | Grant, award, or other acquisition of securities at price $ 5.61 per share. | 06 Sep 2022 | 600 | 225,512 (0%) | 0% | 5.6 | 3,366 | Common Stock |
| Russell Schundler | General Counsel | Grant, award, or other acquisition of securities at price $ 5.69 per share. | 06 Sep 2022 | 32,000 | 257,512 (0%) | 0% | 5.7 | 182,160 | Common Stock |
| Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 4.90 per share. | 31 Aug 2022 | 993 | 116,007 (0%) | 0% | 4.9 | 4,870 | Common Stock |
| Robert A. Lippe | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 4.90 per share. | 31 Aug 2022 | 1,918 | 98,026 (0%) | 0% | 4.9 | 9,407 | Common Stock |
| Michael Kaseta | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 4.90 per share. | 31 Aug 2022 | 1,927 | 29,877 (0%) | 0% | 4.9 | 9,451 | Common Stock |
| Russell Schundler | General Counsel | Grant, award, or other acquisition of securities at price $ 4.90 per share. | 31 Aug 2022 | 2,166 | 224,912 (0%) | 0% | 4.9 | 10,623 | Common Stock |
| Scott Moomaw | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 4.90 per share. | 31 Aug 2022 | 2,160 | 9,810 (0%) | 0% | 4.9 | 10,594 | Common Stock |
| Robert A. Lippe | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Michael Kaseta | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Russell Schundler | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Scott Moomaw | SVP, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Rajeev Saggar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2022 | 200,000 | 200,000 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Rajeev Saggar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2022 | 93,834 | 93,834 (0%) | 0% | 0 | Common Stock | |
| Arthur S. Kirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 931,475 | 931,475 | - | - | Non-Qualified Stock Option (right to buy) | |
| Stephen Bloch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Joanna Horobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Raman Singh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Katherine Rielly-Gauvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Damian deGoa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Michael Kaseta | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.01 per share. | 31 May 2022 | 13,639 | 22,889 (0%) | 0% | 4.0 | 54,692 | Common Stock |
| Michael Kaseta | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 31 May 2022 | 5,061 | 27,950 (0%) | 0% | 4 | 20,244 | Common Stock |
| Roger A. Jeffs | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.53 per share. | 24 May 2022 | 28,000 | 46,595 (0%) | 0% | 3.5 | 98,812 | Common Stock |
| Robert A. Lippe | Chief Operations Officer | Purchase of securities on an exchange or from another person at price $ 3.38 per share. | 24 May 2022 | 29,628 | 90,692 (0%) | 0% | 3.4 | 99,997 | Common Stock |
| Paul B. Manning | Director | Purchase of securities on an exchange or from another person at price $ 5.10 per share. | 18 Apr 2022 | 392,156 | 392,156 (1%) | 1% | 5.1 | 1,999,996 | Common Stock |
| Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2022 | 47,423 | 15,807 | - | - | Restricted Stock Unit | |
| Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2022 | 47,423 | 207,250 (0%) | 0% | - | Common Stock | |
| Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 154,167 | 1,541,667 (5%) | 0% | 0 | Common Stock | |
| Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 435,674 | 435,674 (1%) | 1% | 0 | Common Stock | |
| Russell Schundler | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 2,158 | 222,746 (0%) | 0% | 0 | Common Stock | |
| Damian deGoa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 4,625 | 47,716 (0%) | 0% | 0 | Common Stock | |
| Robert A. Lippe | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2022 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Robert A. Lippe | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2022 | 27,500 | 27,500 | - | - | Restricted Stock Units | |
| Michael Kaseta | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Michael Kaseta | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2022 | 37,500 | 37,500 | - | - | Restricted Stock Units | |
| Russell Schundler | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2022 | 37,500 | 37,500 | - | - | Restricted Stock Units | |
| Russell Schundler | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Scott Moomaw | SVP, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2022 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Scott Moomaw | SVP, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2022 | 30,000 | 30,000 | - | - | Restricted Stock Units | |
| Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 63,230 | 63,230 | - | - | Restricted Stock Unit | |
| Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 1,682,827 | 1,763,180 | - | - | Non-Qualified Stock Option (right to buy) | |
| Russell Schundler | General Counsel | Purchase of securities on an exchange or from another person at price $ 4.28 per share. | 10 Nov 2021 | 39,900 | 160,588 (0%) | 0% | 4.3 | 170,648 | Common Stock |
| Russell Schundler | General Counsel | Purchase of securities on an exchange or from another person at price $ 4.18 per share. | 10 Nov 2021 | 60,000 | 220,588 (0%) | 0% | 4.2 | 250,590 | Common Stock |
| Russell Schundler | General Counsel | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 10 Nov 2021 | 18,008 | 120,688 (0%) | 0% | 4.2 | 75,596 | Common Stock |
| Arthur S. Kirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Stephen Bloch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Paul B. Manning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Joanna Horobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Raman Singh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Katherine Rielly-Gauvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Robert A. Lippe | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Michael Kaseta | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Jason Adair | V.P. Crp Dvlpmnt and Strtgy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Russell Schundler | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Scott Moomaw | SVP, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Damian deGoa | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Russell Schundler | General Counsel | Purchase of securities on an exchange or from another person at price $ 2.78 per share. | 18 May 2021 | 14,500 | 14,500 (0%) | 0% | 2.8 | 40,368 | Common Stock |
| Russell Schundler | General Counsel | Purchase of securities on an exchange or from another person at price $ 2.76 per share. | 18 May 2021 | 41,628 | 61,053 (0%) | 0% | 2.8 | 114,852 | Common Stock |
| Russell Schundler | General Counsel | Purchase of securities on an exchange or from another person at price $ 2.78 per share. | 18 May 2021 | 41,627 | 102,680 (0%) | 0% | 2.8 | 115,598 | Common Stock |
| Roger A. Jeffs | Director | Purchase of securities on an exchange or from another person at price $ 2.52 per share. | 13 Apr 2021 | 99,206 | 111,706 (0%) | 0% | 2.5 | 249,999 | Common Stock |
| Paul B. Manning | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.52 per share. | 13 Apr 2021 | 198,413 | 737,646 (2%) | 0% | 2.5 | 500,001 | Common Stock |
| Russell Schundler | Director, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2021 | 200,000 | 200,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Arthur S. Kirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 41,390 | 41,390 | - | - | Non-Qualified Stock Option (right to buy) | |
| Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 30,353 | 30,353 | - | - | Non-Qualified Stock Option (right to buy) | |
| Stephen Bloch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 55,187 | 55,187 | - | - | Non-Qualified Stock Option (right to buy) | |
| Paul B. Manning | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 21,385 | 21,385 | - | - | Non-Qualified Stock Option (right to buy) | |
| Joanna Horobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 35,872 | 35,872 | - | - | Non-Qualified Stock Option (right to buy) | |
| Raman Singh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 25,524 | 25,524 | - | - | Non-Qualified Stock Option (right to buy) | |
| Katherine Rielly-Gauvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 35,182 | 35,182 | - | - | Non-Qualified Stock Option (right to buy) | |
| Robert A. Lippe | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 51,250 | 51,250 | - | - | Performance Stock Units | |
| Robert A. Lippe | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 102,500 | 102,500 | - | - | Employee Stock Option (right to buy) | |
| Michael Kaseta | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 18,500 | 18,500 | - | - | Employee Stock Option (right to buy) | |
| Michael Kaseta | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 9,250 | 9,250 | - | - | Performance Stock Units | |
| Florina Krawchick | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 55,300 | 55,300 | - | - | Employee Stock Option (right to buy) | |
| Florina Krawchick | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 27,650 | 27,650 | - | - | Performance Stock Units | |
| Scott Moomaw | SVP, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 7,650 | 7,650 | - | - | Performance Stock Units | |
| Scott Moomaw | SVP, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 15,300 | 15,300 | - | - | Employee Stock Option (right to buy) | |
| Arthur S. Kirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ralph Snyderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seth Rudnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Stephen Bloch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Joanna Horobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Raman Singh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Katherine Rielly-Gauvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 20,000 | 20,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Benjamin Maynor | SVP, Research and Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.06 per share. | 27 May 2020 | 2,577 | 9,158 (0%) | 0% | 9.1 | 23,348 | Common Stock |
| Benjamin Maynor | SVP, Research and Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 27 May 2020 | 4,754 | 11,735 (0%) | 0% | 2.7 | 12,788 | Common Stock |
| Benjamin Maynor | SVP, Research and Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2020 | 4,754 | 0 | - | - | Employee Stock Option (right to buy) | |
| Benjamin Maynor | SVP, Research and Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.85 per share. | 14 Apr 2020 | 6,132 | 10,300 (0%) | 0% | 1.8 | 11,344 | Common Stock |
| Benjamin Maynor | SVP, Research and Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2020 | 6,132 | 0 | - | - | Employee Stock Option (right to buy) | |
| Benjamin Maynor | SVP, Research and Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.23 per share. | 14 Apr 2020 | 3,319 | 6,981 (0%) | 0% | 6.2 | 20,677 | Common Stock |
| Richard D. Katz | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2020 | 10,833 | 10,833 (0%) | 0% | 0 | Common Stock | |
| Richard D. Katz | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2020 | 43,333 | 43,333 | - | - | Employee Stock Option (right to buy) | |
| Neal F. Fowler | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2020 | 30,400 | 86,627 (0%) | 0% | 0 | Common Stock | |
| Neal F. Fowler | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2020 | 121,600 | 121,600 | - | - | Employee Stock Option (right to buy | |
| Robert A. Lippe | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2020 | 43,333 | 43,333 | - | - | Employee Stock Option (right to buy) | |
| Robert A. Lippe | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2020 | 10,833 | 28,360 (0%) | 0% | 0 | Common Stock | |
| Benjamin Maynor | SVP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2020 | 33,333 | 33,333 | - | - | Employee Stock Option (right to buy) | |
| Benjamin Maynor | SVP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2020 | 8,333 | 12,501 (0%) | 0% | 0 | Common Stock | |
| Robert Roscigno | SVP, Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2020 | 8,333 | 8,333 (0%) | 0% | 0 | Common Stock | |
| Robert Roscigno | SVP, Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2020 | 33,333 | 33,333 | - | - | Employee Stock Option (right to buy) | |
| Jeri Thomas | SVP, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2020 | 8,333 | 8,333 (0%) | 0% | 0 | Common Stock | |
| Jeri Thomas | SVP, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2020 | 33,333 | 33,333 | - | - | Employee Stock Option (right to buy) | |
| Florina Krawchick | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2020 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Florina Krawchick | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2020 | 7,500 | 16,991 (0%) | 0% | 0 | Common Stock | |
| Stephen Bloch | Director | Grant, award, or other acquisition of securities at price $ 3.13 per share. | 27 Dec 2019 | 319,488 | 2,917,169 (10%) | 1% | 3.1 | 999,997 | Common Stock |
| Katherine Rielly-Gauvin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2019 | 15,000 | 15,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Joanna Horobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2019 | 15,000 | 15,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Arthur S. Kirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2019 | 7,500 | 7,500 | - | - | Nonqualified Stock Option (right to buy) | |
| Ralph Snyderman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2019 | 7,500 | 7,500 | - | - | Nonqualified Stock Option (right to buy) | |
| Seth Rudnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2019 | 7,500 | 7,500 | - | - | Nonqualified Stock Option (right to buy) | |
| Stephen Bloch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2019 | 7,500 | 7,500 | - | - | Nonqualified Stock Option (right to buy) | |
| Raman Singh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2019 | 7,500 | 7,500 | - | - | Nonqualified Stock Option (right to buy) | |
| Timothy Albury | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 22 Aug 2019 | 6,762 | 38,963 (0%) | 0% | 6 | 40,572 | Common Stock |
| Timothy Albury | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2019 | 8,199 | 9,411 | - | - | Incentive Stock Option (right to buy) | |
| Timothy Albury | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.71 per share. | 22 Aug 2019 | 8,199 | 45,725 (0%) | 0% | 4.7 | 38,617 | Common Stock |
| Timothy Albury | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 7.06 per share. | 13 Aug 2019 | 920 | 37,352 (0%) | 0% | 7.1 | 6,495 | Common Stock |
| Timothy Albury | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2019 | 640 | 17,610 | - | - | Incentive Stock Option (right to buy) | |
| Timothy Albury | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2019 | 1,361 | 18,250 | - | - | Incentive Stock Option (right to buy) | |
| Timothy Albury | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 6.50 per share. | 13 Aug 2019 | 466 | 37,526 (0%) | 0% | 6.5 | 3,029 | Common Stock |
| Timothy Albury | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.71 per share. | 13 Aug 2019 | 640 | 37,992 (0%) | 0% | 4.7 | 3,014 | Common Stock |
| Timothy Albury | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.71 per share. | 13 Aug 2019 | 1,361 | 38,272 (0%) | 0% | 4.7 | 6,410 | Common Stock |
| Richard D. Katz | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2019 | 155,000 | 155,000 | - | - | Employee Stock Option (right to buy) | |
| Ralph Snyderman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 24 Apr 2019 | 946 | 25,808 (0%) | 0% | 2.7 | 2,545 | Common Stock |
| Ralph Snyderman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2019 | 4,085 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ralph Snyderman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2019 | 463 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ralph Snyderman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2019 | 946 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ralph Snyderman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.71 per share. | 24 Apr 2019 | 4,085 | 30,356 (0%) | 0% | 4.7 | 19,240 | Common Stock |
| Ralph Snyderman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.87 per share. | 24 Apr 2019 | 463 | 26,271 (0%) | 0% | 3.9 | 1,792 | Common Stock |
| Stephen Bloch | Director | 04 Mar 2019 | 34,378 | 0 | - | - | Warrant to purchase Common Stock | ||
| Stephen Bloch | Director | 04 Mar 2019 | 34,378 | 2,597,681 (9%) | 0% | 0.0 | 344 | Common Stock | |
| Benjamin Maynor | SVP, Research and Development | Sale of securities on an exchange or to another person at price $ 18.96 per share. | 28 Feb 2019 | 50 | 6,305 (0%) | 0% | 19.0 | 948 | Common Stock |
| Benjamin Maynor | SVP, Research and Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 2,187 | 6,132 | - | - | Employee Stock Option (right to buy) | |
| Benjamin Maynor | SVP, Research and Development | Sale of securities on an exchange or to another person at price $ 19.86 per share. | 28 Feb 2019 | 2,137 | 4,168 (0%) | 0% | 19.9 | 42,441 | Common Stock |
| Benjamin Maynor | SVP, Research and Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.85 per share. | 28 Feb 2019 | 2,187 | 6,355 (0%) | 0% | 1.9 | 4,046 | Common Stock |
| Kevin K. Gordon | President and CFO | Sale of securities on an exchange or to another person at price $ 16.83 per share. | 22 Feb 2019 | 212 | 162,703 (0%) | 0% | 16.8 | 3,568 | Common Stock |
| Kevin K. Gordon | President and CFO | Sale of securities on an exchange or to another person at price $ 18.09 per share. | 22 Feb 2019 | 438 | 162,265 (0%) | 0% | 18.1 | 7,923 | Common Stock |
| Kevin K. Gordon | President and CFO | Sale of securities on an exchange or to another person at price $ 15.83 per share. | 22 Feb 2019 | 293 | 162,915 (0%) | 0% | 15.8 | 4,638 | Common Stock |
| Neal F. Fowler | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2019 | 96,500 | 96,500 | - | - | Employee Stock Option (right to buy) | |
| Robert A. Lippe | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2019 | 36,000 | 36,000 | - | - | Employee Stock Option (right to buy) | |
| Benjamin Maynor | SVP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2019 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Robert Roscigno | SVP, Product Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2019 | 36,000 | 36,000 | - | - | Employee Stock Option (right to buy) | |
| Timothy Albury | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2019 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) | |
| Jeri Thomas | SVP, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2019 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Kevin K. Gordon | President and CFO | Sale of securities on an exchange or to another person at price $ 14.84 per share. | 22 Jan 2019 | 8,355 | 163,208 (0%) | 0% | 14.8 | 123,988 | Common Stock |
| Kevin K. Gordon | President and CFO | Sale of securities on an exchange or to another person at price $ 14.14 per share. | 22 Jan 2019 | 2,967 | 171,563 (0%) | 0% | 14.1 | 41,953 | Common Stock |
| Arthur S. Kirsch | None | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 13 Nov 2018 | 105 | 1,105 (0%) | 0% | 18 | 1,890 | Common Stock |
| Arthur S. Kirsch | None | Purchase of securities on an exchange or from another person at price $ 18.50 per share. | 13 Nov 2018 | 895 | 2,000 (0%) | 0% | 18.5 | 16,558 | Common Stock |
| Arthur S. Kirsch | None | Purchase of securities on an exchange or from another person at price $ 18.25 per share. | 08 Nov 2018 | 1,000 | 1,000 (0%) | 0% | 18.3 | 18,250 | Common Stock |
| Kevin K. Gordon | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 5,870 | 174,530 (1%) | 0% | 0 | Common Stock | |
| Neal F. Fowler | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2018 | 11,238 | 56,227 (0%) | 0% | 0 | Common Stock | |
| Timothy Albury | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2018 | 7,713 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Timothy Albury | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2018 | 3,130 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Timothy Albury | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.46 per share. | 13 Sep 2018 | 2,157 | 36,911 (0%) | 0% | 19.5 | 41,975 | Common Stock |
| Timothy Albury | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.87 per share. | 13 Sep 2018 | 10,843 | 39,068 (0%) | 0% | 3.9 | 41,962 | Common Stock |
| Arthur M. Pappas | Ten Percent Owner | 30 Jul 2018 | 97,287 | 289,075 (1%) | 0% | 0 | Common Stock, par value $0.001 per share | ||
| Arthur M. Pappas | Ten Percent Owner | 30 Jul 2018 | 191,788 | 191,788 (1%) | 1% | 0 | Common Stock, par value $0.001 per share | ||
| Arthur M. Pappas | Ten Percent Owner | 30 Jul 2018 | 1,481,553 | 0 | - | - | Series C Preferred Stock, par value $0.001 per share | ||
| Arthur M. Pappas | Ten Percent Owner | 30 Jul 2018 | 1,637,091 | 0 | - | - | Series D Preferred Stock, par value $0.001 per share | ||
| M. James Barrett | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Jul 2018 | 40,702 | 40,702 | - | - | Warrant to purchase Common Stock | |
| M. James Barrett | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.00 per share. | 30 Jul 2018 | 545,455 | 2,484,870 (16%) | 3% | 11 | 6,000,005 | Common Stock |
| M. James Barrett | Ten Percent Owner | 30 Jul 2018 | 980,715 | 1,939,415 (12%) | 6% | 0 | Common Stock | ||
| M. James Barrett | Ten Percent Owner | 30 Jul 2018 | 432,033 | 958,700 (6%) | 2% | 0 | Common Stock | ||
| M. James Barrett | Ten Percent Owner | 30 Jul 2018 | 515,547 | 526,667 (3%) | 3% | 0 | Common Stock | ||
| M. James Barrett | Ten Percent Owner | 30 Jul 2018 | 3,645,307 | 0 | - | - | Series B Preferred Stock | ||
| M. James Barrett | Ten Percent Owner | 30 Jul 2018 | 3,337,206 | 0 | - | - | Series C Preferred Stock | ||
| M. James Barrett | Ten Percent Owner | 30 Jul 2018 | 16,502,833 | 0 | - | - | Series D Preferred Stock | ||
| M. James Barrett | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Jul 2018 | 684,911 | 0 | - | - | Warrant to purchase Series D Preferred Stock | |
| Peter J. Barris | Ten Percent Owner | 30 Jul 2018 | 432,033 | 958,700 (6%) | 2% | 0 | Common Stock | ||
| Peter J. Barris | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.00 per share. | 30 Jul 2018 | 545,455 | 2,484,870 (16%) | 3% | 11 | 6,000,005 | Common Stock |
| Peter J. Barris | Ten Percent Owner | 30 Jul 2018 | 980,715 | 1,939,415 (12%) | 6% | 0 | Common Stock | ||
| Peter J. Barris | Ten Percent Owner | 30 Jul 2018 | 515,547 | 526,667 (3%) | 3% | 0 | Common Stock | ||
| Peter J. Barris | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Jul 2018 | 40,702 | 40,702 | - | - | Warrant to purchase Common Stock | |
| Peter J. Barris | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Jul 2018 | 684,911 | 0 | - | - | Warrant to purchase Series D Preferred Stock | |
| Peter J. Barris | Ten Percent Owner | 30 Jul 2018 | 16,502,833 | 0 | - | - | Series D Preferred Stock | ||
| Peter J. Barris | Ten Percent Owner | 30 Jul 2018 | 3,337,206 | 0 | - | - | Series C Preferred Stock | ||
| Peter J. Barris | Ten Percent Owner | 30 Jul 2018 | 3,645,307 | 0 | - | - | Series B Preferred Stock | ||
| Sandell D Scott | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Jul 2018 | 40,702 | 40,702 | - | - | Warrant to purchase Common Stock | |
| Sandell D Scott | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Jul 2018 | 684,911 | 0 | - | - | Warrant to purchase Series D Preferred Stock | |
| Sandell D Scott | Ten Percent Owner | 30 Jul 2018 | 16,502,833 | 0 | - | - | Series D Preferred Stock | ||
| Sandell D Scott | Ten Percent Owner | 30 Jul 2018 | 3,337,206 | 0 | - | - | Series C Preferred Stock | ||
| Sandell D Scott | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.00 per share. | 30 Jul 2018 | 545,455 | 2,484,870 (16%) | 3% | 11 | 6,000,005 | Common Stock |
| Sandell D Scott | Ten Percent Owner | 30 Jul 2018 | 515,547 | 526,667 (3%) | 3% | 0 | Common Stock | ||
| Sandell D Scott | Ten Percent Owner | 30 Jul 2018 | 432,033 | 958,700 (6%) | 2% | 0 | Common Stock | ||
| Sandell D Scott | Ten Percent Owner | 30 Jul 2018 | 980,715 | 1,939,415 (12%) | 6% | 0 | Common Stock | ||
| Sandell D Scott | Ten Percent Owner | 30 Jul 2018 | 3,645,307 | 0 | - | - | Series B Preferred Stock | ||
| Forest Baskett | Ten Percent Owner | 30 Jul 2018 | 16,502,833 | 0 | - | - | Series D Preferred Stock | ||
| Forest Baskett | Ten Percent Owner | 30 Jul 2018 | 3,337,206 | 0 | - | - | Series C Preferred Stock | ||
| Forest Baskett | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.00 per share. | 30 Jul 2018 | 545,455 | 2,484,870 (16%) | 3% | 11 | 6,000,005 | Common Stock |
| Forest Baskett | Ten Percent Owner | 30 Jul 2018 | 3,645,307 | 0 | - | - | Series B Preferred Stock | ||
| Forest Baskett | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Jul 2018 | 40,702 | 40,702 | - | - | Warrant to purchase Common Stock | |
| Forest Baskett | Ten Percent Owner | 30 Jul 2018 | 515,547 | 526,667 (3%) | 3% | 0 | Common Stock | ||
| Forest Baskett | Ten Percent Owner | 30 Jul 2018 | 432,033 | 958,700 (6%) | 2% | 0 | Common Stock | ||
| Forest Baskett | Ten Percent Owner | 30 Jul 2018 | 980,715 | 1,939,415 (12%) | 6% | 0 | Common Stock | ||
| Forest Baskett | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Jul 2018 | 684,911 | 0 | - | - | Warrant to purchase Series D Preferred Stock | |
| Stephen Bloch | None | 30 Jul 2018 | 89,630 | 180,166 (1%) | 0% | 0 | Common Stock | ||
| Stephen Bloch | None | 30 Jul 2018 | 15,887,155 | 0 | - | - | Series D Preferred Stock | ||
| Stephen Bloch | None | Other type of transaction at price $ 0.00 per share. | 30 Jul 2018 | 578,498 | 0 | - | - | Warrant to purchase Series D Preferred Stock | |
| Stephen Bloch | None | Other type of transaction at price $ 0.00 per share. | 30 Jul 2018 | 34,378 | 34,378 | - | - | Warrant to purchase Common Stock | |
| Stephen Bloch | None | 30 Jul 2018 | 918,657 | 0 | - | - | Series A Preferred Stock | ||
| Stephen Bloch | None | 30 Jul 2018 | 650,427 | 0 | - | - | Series A-1 Preferred Stock | ||
| Stephen Bloch | None | 30 Jul 2018 | 222,529 | 0 | - | - | Series B Preferred Stock | ||
| Stephen Bloch | None | 30 Jul 2018 | 5,254,658 | 0 | - | - | Series C Preferred Stock | ||
| Stephen Bloch | None | Purchase of securities on an exchange or from another person at price $ 11.00 per share. | 30 Jul 2018 | 727,273 | 2,563,303 (16%) | 4% | 11 | 8,000,003 | Common Stock |
| Stephen Bloch | None | 30 Jul 2018 | 944,127 | 1,836,030 (12%) | 6% | 0 | Common Stock | ||
| Stephen Bloch | None | 30 Jul 2018 | 680,266 | 891,903 (5%) | 4% | 0 | Common Stock | ||
| Stephen Bloch | None | 30 Jul 2018 | 31,471 | 211,637 (1%) | 0% | 0 | Common Stock | ||
| Stephen Bloch | None | 30 Jul 2018 | 87,837 | 90,536 (0%) | 0% | 0 | Common Stock | ||
| Patrick J. Kerins | Ten Percent Owner | 30 Jul 2018 | 3,645,307 | 0 | - | - | Series B Preferred Stock | ||
| Patrick J. Kerins | Ten Percent Owner | 30 Jul 2018 | 3,337,206 | 0 | - | - | Series C Preferred Stock | ||
| Patrick J. Kerins | Ten Percent Owner | 30 Jul 2018 | 16,502,833 | 0 | - | - | Series D Preferred Stock | ||
| Patrick J. Kerins | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Jul 2018 | 684,911 | 0 | - | - | Warrant to purchase Series D Preferred Stock | |
| Patrick J. Kerins | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 30 Jul 2018 | 40,702 | 40,702 | - | - | Warrant to purchase Common Stock | |
| Patrick J. Kerins | Ten Percent Owner | 30 Jul 2018 | 515,547 | 526,667 (3%) | 3% | 0 | Common Stock | ||
| Patrick J. Kerins | Ten Percent Owner | 30 Jul 2018 | 432,033 | 958,700 (6%) | 2% | 0 | Common Stock | ||
| Patrick J. Kerins | Ten Percent Owner | 30 Jul 2018 | 980,715 | 1,939,415 (12%) | 6% | 0 | Common Stock | ||
| Patrick J. Kerins | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 11.00 per share. | 30 Jul 2018 | 545,455 | 2,484,870 (16%) | 3% | 11 | 6,000,005 | Common Stock |
| Arthur S. Kirsch | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 10,050 | 10,050 | - | - | Stock Option | |
| Edward T. Mathers | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 26,986 | 26,986 | - | - | Stock Option | |
| Kevin K. Gordon | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 41,084 | 168,660 | - | - | Restricted Stock UnitA | |
| Kevin K. Gordon | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 41,084 | 41,084 | - | - | Stock Option | |
| Stephen Bloch | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 26,986 | 26,986 | - | - | Stock Option (right to buy) | |
| Neal F. Fowler | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 192,008 | 192,008 | - | - | Stock Option | |
| Raman Singh | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2018 | 10,050 | 10,050 | - | - | Stock Option |